Showing 2766 results
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LR Phase III APPEAR-C3G study met its primary endpoint, demonstrating superiority of iptacopan vs. placebo in proteinuria reduction at six-month analysis1;…
Pagination
- ‹ Previous page
- 1
- …
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- …
- 277
- › Next page